Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €10.04 EUR
Change Today -0.084 / -0.83%
Volume 0.0
MXE On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 2:01 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for mimedx group inc (MXE)

Year over year, MiMedx Group, Inc. has been able to grow revenues from $59.2M USD to $118.2M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 15.76% to 10.71%. This was a driver that led to a bottom line growth from a loss of $4.1M USD to a gain of $6.2M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Restated
Dec 31
2013
Restated
Dec 31
2014
4 Year
Trend
Revenues7.827.159.2118.2
TOTAL REVENUES7.827.159.2118.2
Cost of Goods Sold3.45.29.312.7
GROSS PROFIT4.421.949.9105.6
Selling General & Admin Expenses, Total9.819.646.290.5
R&D Expenses3.02.94.87.1
Depreciation & Amortization, Total1.31.41.10.9
OTHER OPERATING EXPENSES, TOTAL14.223.952.198.5
OPERATING INCOME-9.8-2.0-2.27.1
Interest Expense-0.4-2.3-1.40.0
NET INTEREST EXPENSE-0.4-2.3-1.40.0
EBT, EXCLUDING UNUSUAL ITEMS-10.2-4.3-3.67.1
Merger & Restructuring Charges----0.0--
Other Unusual Items, Total0.0-3.4-0.4--
Other Unusual Items0.0-1.6----
EBT, INCLUDING UNUSUAL ITEMS-10.2-7.7-4.07.1
Income Tax Expense----0.10.8
Earnings from Continuing Operations-10.2-7.7-4.16.2
NET INCOME-10.2-7.7-4.16.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-10.2-7.7-4.16.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-10.2-7.7-4.16.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MXE:GR €10.04 EUR -0.084

MXE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alliqua BioMedical Inc $4.94 USD 0.00
Derma Sciences Inc $7.13 USD +0.18
Medtronic PLC $78.28 USD +0.40
Osiris Therapeutics Inc $21.05 USD +0.15
Smith & Nephew PLC 1,167 GBp +32.00
View Industry Companies
 

Industry Analysis

MXE

Industry Average

Valuation MXE Industry Range
Price/Earnings 100.0x
Price/Sales 9.4x
Price/Book 15.6x
Price/Cash Flow 110.9x
TEV/Sales 9.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIMEDX GROUP INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.